Intellectual Property India Publishes Patent Application for Functionalized Tetrahydropyrimidine–thiazolidinone Scaffolds And Derivatives Thereof And Its Anticancer Activity

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202621110117 A) filed by Dnyaneshwar Bhaguji Hardas; and Dr. Ramesh Lakshman Sawant on September 14, 2026, for Functionalized Tetrahydropyrimidine–thiazolidinone Scaffolds And Derivatives Thereof And Its Anticancer Activity.

Inventors include Dnyaneshwar Bhaguji Hardas; and Dr. Ramesh Lakshman Sawant.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: “FUNCTIONALIZED TETRAHYDROPYRIMIDINE–THIAZOLIDINONE SCAFFOLDS AND DERIVATIVES THEREOF AND ITS ANTICANCER ACTIVITY” Cancer is the global cause of death worldwide. Anticancer drug development is the need for today’s scenario. In present invention a series ...